Next Article in Journal
Hepatitis C Virus: Viral Quasispecies and Genotypes
Next Article in Special Issue
The Crosstalk between Nrf2 and Inflammasomes
Previous Article in Journal
Docosahexaenoic Acid in Combination with Dietary Energy Restriction for Reducing the Risk of Obesity Related Breast Cancer
Previous Article in Special Issue
Nrf2, the Master Regulator of Anti-Oxidative Responses
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2018, 19(1), 26;

Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling

Department of Food and Nutrition, Eulji University, Seongnam 13135, Korea
College of Pharmacy and Gachon Institute of Pharmaceutical Science, Gachon University, Incheon 21936, Korea
Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, Korea
Gachon Medical Research Institute, Gil Hospital, Incheon 21565, Korea
Author to whom correspondence should be addressed.
Received: 25 November 2017 / Revised: 19 December 2017 / Accepted: 20 December 2017 / Published: 22 December 2017
(This article belongs to the Special Issue Nrf2 in Redox Signaling: A Double Edged Sword)
Full-Text   |   PDF [867 KB, uploaded 22 December 2017]   |  


Oxidative cellular damage caused by free radicals is known to contribute to the pathogenesis of various diseases such as cancer, diabetes, and neurodegenerative diseases, as well as to aging. The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein1 (Keap1) signaling pathways play an important role in preventing stresses including oxidative and inflammatory stresses. Nrf2 is a master regulator of cellular stress responses, induces the expression of antioxidant and detoxification enzymes, and protects against oxidative stress-induced cell damage. Glucagon-like peptide-1 (GLP-1) is an incretin hormone, which was originally found to increase insulin synthesis and secretion. It is now widely accepted that GLP-1 has multiple functions beyond glucose control in various tissues and organs including brain, kidney, and heart. GLP-1 and GLP-1 receptor agonists are known to be effective in many chronic diseases, including diabetes, via antioxidative mechanisms. In this review, we summarize the current knowledge regarding the role of GLP-1 in the protection against oxidative damage and the activation of the Nrf2 signaling pathway. View Full-Text
Keywords: oxidative stress; reactive oxygen species; Nrf2 signaling; diabetes; glucagon-like peptide-1 oxidative stress; reactive oxygen species; Nrf2 signaling; diabetes; glucagon-like peptide-1

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Oh, Y.S.; Jun, H.-S. Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling. Int. J. Mol. Sci. 2018, 19, 26.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top